CREDENCE: Canagliflozin reduces the risk of kidney failure or death due to CV or kidney disease by 30% compared to current standard of care ca. 2019 from @NEJM
#VisualAbstract by @brendonneuen
#NKFClinicals 🇺🇸 #Nephpearls
👉🏼 nejm.org/doi/pdf/10.105…
CREDENCE: Summary of Key Renal and CV Outcomes from @gbakris
#NKFClinicals 🇺🇸 #Nephpearls
👉🏼 nejm.org/doi/pdf/10.105…
Whether the increased risk of lower limb amputation in the CANVAS Program was due to differing trial populations or protocols, or to chance remains unclear
#NKFClinicals 🇺🇸 #Nephpearls
👉🏼 nejm.org/doi/pdf/10.105…
CREDENCE: Primary Outcome - Benefits in eGFR 30 to < 45 subgroup
#NKFClinicals 🇺🇸 #Nephpearls
👉🏼 nejm.org/doi/pdf/10.105…
Check out 👉🏼 SGLT2 Inhibitors and #Cardiorenal outcomes, which was written by @brendonneuen @kidney_boy and myself‼️
📌 This was our choice for ⚡️Kidney Watch 2019⚡️ published in the February 2019 issue of @KidneyNews
#NKFClinicals 🇺🇸 #Nephpearls
👉🏼 kidneynews.org/kidneynews/11_…
Renoprotective effects of SGLT2 Inhibitors ca. 2018 from @Kidney_Int
#NKFClinicals 🇺🇸 #Nephpearls
👉🏼 kidney-international.org/article/S0085-…
Diabetes and Kidney Disease: SGLT2 Inhibitors by @ChristosArgyrop in the August 2019 issue of @KidneyNews #Nephpearls
👉🏼 asn-online.org/publications/k…
How does CREDENCE Inform Best Use of SGLT2 Inhibitors in CKD ⁉️ ca. 2019 from @CJASN #Nephpearls
👉🏼 cjasn.asnjournals.org/content/early/…
SGLT2 Inhibition Heralds a Call-to-Action for Diabetic Kidney Disease ca. 2019 from @CJASN #Nephpearls
👉🏼 cjasn.asnjournals.org/content/early/…
Key 🔑 patient characteristics and concomitant drug use influencing the decision to use SGLT2 inhibitors ca. 2020 from @NDTsocial @brendonneuen @jardine_meg @VladoPerkovic #Nephpearls
👉🏼 academic.oup.com/ndt/article/35…
Dapagliflozin was effective at reducing cardiovascular morbidity and mortality in patients with heart failure and reduced ejection fraction independent of diabetes status ca. 2020 from @JAMA_current #Nephpearls
👉🏼 jamanetwork.com/journals/jama/…
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.